KOTAI Biotechnologies Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$7.1M
KOTAI Biotechnologies General Information
Description
Provider of immuno-informatics services designed for drug discovery and clinical research. The company's services utilize ai-based big data analysis and three-dimensional molecular simulation to provide immune repertoire analysis, biomarker identification and target exploration, enabling pharmaceutical companies and research institutes to access novel therapeutic candidates and patient stratification data for cancer and autoimmune diseases.
Contact Information
Website
www.kotai-bio.com(Operating Subsidiary)
Corporate Office
- 7th Floor, Minoh Senri Building
- 3-4-17 Senba Higashi
- Minoh City, Osaka Prefecture 562-0035
- Japan
Corporate Office
- 7th Floor, Minoh Senri Building
- 3-4-17 Senba Higashi
- Minoh City, Osaka Prefecture 562-0035
- Japan
KOTAI Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 31-Jul-2023 | $7.1M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series C) | 28-Oct-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 28-Aug-2017 | $1.83M | $2.32M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 21-Oct-2016 | $487K | $487K | Completed | Startup |
KOTAI Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C preferred | ||||||||
| B preferred | ||||||||
| A preferred | 2,500 | $189.86 | $189.86 | 1x | $189.86 | 7.37% |
KOTAI Biotechnologies Patents
KOTAI Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024354738-A1 | Coronavirus spike protein variants | Pending | 06-Oct-2023 | ||
| EP-4790065-A1 | Coronavirus spike protein variants | Pending | 06-Oct-2023 | ||
| WO-2025075129-A1 | Coronavirus spike protein variants | Inactive | 06-Oct-2023 | ||
| JP-2022187385-A | Antibodies against sars-cov-2 spike protein | Pending | 07-Jun-2021 | ||
| EP-4310095-A1 | Follicular helper t (tfh) cells specific to sars-cov-2 virus | Inactive | 16-Mar-2021 | A61K39/12 |
KOTAI Biotechnologies Signals
KOTAI Biotechnologies Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amashin-Shinkin | Venture Capital | Minority | ||
| Japan Agency for Medical Research and Development | Government | Minority | ||
| Minato Growing Enterprises | Venture Capital | Minority | ||
| New Energy and Industrial Technology Development Organization | Government | Minority | ||
| Nippon Venture Capital | Corporate Venture Capital | Minority |
KOTAI Biotechnologies FAQs
-
When was KOTAI Biotechnologies founded?
KOTAI Biotechnologies was founded in 2016.
-
Where is KOTAI Biotechnologies headquartered?
KOTAI Biotechnologies is headquartered in Minoh City, Japan.
-
What is the size of KOTAI Biotechnologies?
KOTAI Biotechnologies has 11 total employees.
-
What industry is KOTAI Biotechnologies in?
KOTAI Biotechnologies’s primary industry is Biotechnology.
-
Is KOTAI Biotechnologies a private or public company?
KOTAI Biotechnologies is a Private company.
-
What is the current valuation of KOTAI Biotechnologies?
The current valuation of KOTAI Biotechnologies is .
-
What is KOTAI Biotechnologies’s current revenue?
The current revenue for KOTAI Biotechnologies is .
-
How much funding has KOTAI Biotechnologies raised over time?
KOTAI Biotechnologies has raised $4.79M.
-
Who are KOTAI Biotechnologies’s investors?
Amashin-Shinkin, Japan Agency for Medical Research and Development, Minato Growing Enterprises, New Energy and Industrial Technology Development Organization, and Nippon Venture Capital are 5 of 8 investors who have invested in KOTAI Biotechnologies.
-
When was KOTAI Biotechnologies acquired?
KOTAI Biotechnologies was acquired on 31-Jul-2023.
-
Who acquired KOTAI Biotechnologies?
KOTAI Biotechnologies was acquired by Sanyo Trading Co..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process